Related references
Note: Only part of the references are listed.Diagnostic performance of 18F-FDG-PET/CT in DTC patients with thyroglobulin elevation and negative iodine scintigraphy: a meta-analysis
Wan Qichang et al.
EUROPEAN JOURNAL OF ENDOCRINOLOGY (2019)
Diffusion-weighted MRI is not superior to FDG-PET/CT for the detection of neck recurrence in well-differentiated thyroid carcinoma
Pierre Vera et al.
QUARTERLY JOURNAL OF NUCLEAR MEDICINE AND MOLECULAR IMAGING (2019)
The current and evolving role of FDG-PET/CT in personalized iodine-131 therapy of differentiated thyroid cancer
Leonardo Pace et al.
CLINICAL AND TRANSLATIONAL IMAGING (2017)
[18F]FDG PET/CT outperforms [18F]FDG PET/MRI in differentiated thyroid cancer
Alexis Vrachimis et al.
EUROPEAN JOURNAL OF NUCLEAR MEDICINE AND MOLECULAR IMAGING (2016)
Imaging with 124I in differentiated thyroid carcinoma: is PET/MRI superior to PET/CT?
I. Binse et al.
EUROPEAN JOURNAL OF NUCLEAR MEDICINE AND MOLECULAR IMAGING (2016)
Evaluation of 124I PET/CT and 124I PET/MRI in the management of patients with differentiated thyroid cancer
Laurent Dercle et al.
EUROPEAN JOURNAL OF NUCLEAR MEDICINE AND MOLECULAR IMAGING (2016)
2015 American Thyroid Association Management Guidelines for Adult Patients with Thyroid Nodules and Differentiated Thyroid Cancer The American Thyroid Association Guidelines Task Force on Thyroid Nodules and Differentiated Thyroid Cancer
Bryan R. Haugen et al.
THYROID (2016)
Impact of combined FDG-PET/CT and MRI on the detection of local recurrence and nodal metastases in thyroid cancer
Johann-Martin Hempel et al.
CANCER IMAGING (2016)
Radiation dosimetry of 18F-FDG PET/CT: incorporating exam-specific parameters in dose estimates
Brian Quinn et al.
BMC MEDICAL IMAGING (2016)
Accuracy of MRI for the diagnosis of metastatic cervical lymphadenopathy in patients with thyroid cancer
Qinghua Chen et al.
RADIOLOGIA MEDICA (2015)
Postoperative Fluorine-18-Fluorodeoxyglucose Positron Emission Tomography/Computed Tomography: An Important Imaging Modality in Patients with Aggressive Histology of Differentiated Thyroid Cancer
Camila Nascimento et al.
THYROID (2015)
FDG PET/CT: EANM procedure guidelines for tumour imaging: version 2.0
Ronald Boellaard et al.
EUROPEAN JOURNAL OF NUCLEAR MEDICINE AND MOLECULAR IMAGING (2015)
Detection and quantification of focal uptake in head and neck tumours: 18F-FDG PET/MR versus PET/CT
Arthur Varoquaux et al.
EUROPEAN JOURNAL OF NUCLEAR MEDICINE AND MOLECULAR IMAGING (2014)
Whole-body PET/MRI in oncology: current status and clinical applications
Leonardo Pace et al.
CLINICAL AND TRANSLATIONAL IMAGING (2013)
Postradioiodine Treatment Whole-Body Scan in the Era of 18-Fluorodeoxyglucose Positron Emission Tomography for Differentiated Thyroid Carcinoma with Elevated Serum Thyroglobulin Levels
Sophie Leboulleux et al.
THYROID (2012)
Do histological, immunohistochemical, and metabolic (radioiodine and fluorodeoxyglucose uptakes) patterns of metastatic thyroid cancer correlate with patient outcome?
D. Deandreis et al.
ENDOCRINE-RELATED CANCER (2011)
Utility of PET/Neck MRI digital fusion images in the management of recurrent or persistent thyroid cancer
Laura Seiboth et al.
THYROID (2008)
The role of PET in follow-up of patients treated for differentiated epithelial thyroid cancers
Sophie Leboulleux et al.
NATURE CLINICAL PRACTICE ENDOCRINOLOGY & METABOLISM (2007)
Real-time prognosis for metastatic thyroid carcinoma based on 2-[18F]fluoro-2-deoxy-D-glucose-positron emission tomography scanning
RJ Robbins et al.
JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM (2006)
Recombinant human thyrotropin-stimulated serum thyroglobulin combined with neck ultrasonography has the highest sensitivity in monitoring differentiated thyroid carcinoma
F Pacini et al.
JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM (2003)
Positive predictive value of serum thyroglobulin levels, measured during the first year of follow-up after thyroid hormone withdrawal, in thyroid cancer patients
E Baudin et al.
JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM (2003)
Share Paper
